Intern, Environmental Health and Safety

The intern will work with the EHS Team to build/improve eLearning Modules; assisting with the development of Emergency Action Plans for events such as Loss of Power, Chemical Spill; Medical Emergency, Smoke/Fire. As well as:

* Assist the EHS Team with continuous improvement of various aspects of our EHS Management System Framework

* Conduct area inspections

* Assist with development or updating EHS programs

* Audit Chemical Inventory System

* Support the new ergonomic assessment tool rollout

* Work on sustainability-related projects

* Utilize common personal protective equipment used in the laboratory and industrial settings

* Learn and Work with Industrial Hygiene Instrumentation.

Learning Outcomes

* Understand the day-to-day tasks and challenges of managing EHS in the Biopharmaceutical Industry.

* Demonstrate proficiency as a junior EHS professional via a variety of program/situational exposures.

* Recommend program changes through engagement with key customers and understanding of compliance obligations.

* Become familiar with local, state, and federal regulatory environment and how it applies to the biopharmaceutical industry.

* Apply learnings throughout the internship to have a measurable improvement in 1 or more of the Site EHS Programs.

Qualifications

* Enrolled in an undergraduate program in Occupational Health & Safety, Environment, or similar

* Working knowledge of PowerPoint, Word and Excel

* Good written and verbal communication skills; attention to detail; motivated and energetic

* Interest in OSHA compliance and understanding of basic OSHA safety programs for general industry and MassDEP/EPA environmental regulations.

* Be capable of traveling independently to our various Massachusetts Facilities

* Legal authorization to work in the U.S.

* At least 18 years of age prior to scheduled start date

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.